| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.61▲ | 19.61▲ | 19.61▲ | 19.55▲ | 19.47▲ |
| MA10 | 19.53▲ | 19.53▲ | 19.55▲ | 19.46▲ | 19.52▲ |
| MA20 | 19.55▲ | 19.55▲ | 19.53▲ | 19.47▲ | 19.52▲ |
| MA50 | 19.52▲ | 19.51▲ | 19.51▲ | 19.54▲ | 19.32▲ |
| MA100 | 19.41▲ | 19.37▲ | 19.37▲ | 19.45▲ | 19.43▲ |
| MA200 | 19.23▲ | 19.29▲ | 19.27▲ | 19.25▲ | 19.48▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | 0.018▲ | 0.017▲ | 0.021▲ | -0.008▼ |
| RSI | 56.129▲ | 56.049▲ | 55.697▲ | 53.027▲ | 51.511▲ |
| STOCH | 67.929 | 71.601 | 68.570 | 74.572 | 48.782 |
| WILL %R | -3.774▲ | -3.774▲ | -3.774▲ | -23.653▲ | -47.643 |
| CCI | 62.826 | 77.077 | 77.067 | 124.757▲ | 43.545 |
|
Wednesday, June 18, 2025 04:00 AM
WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the ...
|
|
Tuesday, May 28, 2024 02:42 PM
This data feed is not available at this time. Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.
|
|
Thursday, April 11, 2024 03:31 PM
This data feed is not available at this time. Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 19.71 | 19.71 | 19.5497 | 19.5497 | 1,304 |
| 29/12/25 | 19.47 | 19.72 | 19.47 | 19.584 | 2,600 |
| 26/12/25 | 19.45 | 19.69 | 19.45 | 19.5615 | 925 |
| 24/12/25 | 19.64 | 19.64 | 19.58 | 19.58 | 1,400 |
| 23/12/25 | 19.36 | 19.52 | 19.36 | 19.4518 | 1,670 |
| 22/12/25 | 19.20 | 19.427 | 19.20 | 19.427 | 1,300 |
| 19/12/25 | 19.40 | 19.40 | 19.316 | 19.316 | 700 |
| 18/12/25 | 19.549 | 19.549 | 19.3685 | 19.3685 | 264 |
| 17/12/25 | 19.459 | 19.459 | 19.391 | 19.391 | 500 |
| 16/12/25 | 19.44 | 19.56 | 19.338 | 19.338 | 1,600 |
|
|
||||
|
|
||||
|
|